MARTIAN CLINICAL CONSULTING Trademark

Trademark Overview

On Thursday, March 23, 2023, a trademark application was filed for MARTIAN CLINICAL CONSULTING with the United States Patent and Trademark Office. The USPTO has given the MARTIAN CLINICAL CONSULTING trademark a serial number of 97853900. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, May 13, 2024. The MARTIAN CLINICAL CONSULTING trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Clinical medical consulting for oncology drug development, pediatric drug development, medical affairs, regulatory strategy
martian clinical consulting

General Information

Serial Number97853900
Word MarkMARTIAN CLINICAL CONSULTING
Filing DateThursday, March 23, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, May 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 10, 2023

Trademark Statements

Goods and ServicesClinical medical consulting for oncology drug development, pediatric drug development, medical affairs, regulatory strategy
NOT AVAILABLECLINICAL CONSULTING

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 28, 2023
Primary Code044
First Use Anywhere DateWednesday, March 1, 2023
First Use In Commerce DateWednesday, March 15, 2023

Trademark Owner History

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressSan Francisco, CA 94107
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressSan Francisco, CA 94107

Trademark Events

Event DateEvent Description
Tuesday, March 28, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 27, 2023NEW APPLICATION ENTERED
Friday, August 11, 2023ASSIGNED TO EXAMINER
Thursday, August 17, 2023NON-FINAL ACTION WRITTEN
Thursday, August 17, 2023NON-FINAL ACTION E-MAILED
Thursday, August 17, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 25, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 25, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, August 26, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, September 2, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 10, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 5, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, December 23, 2023USE AMENDMENT FILED
Saturday, December 23, 2023TEAS STATEMENT OF USE RECEIVED
Saturday, January 13, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, January 13, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, May 13, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, May 13, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sunday, January 14, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, January 14, 2024SU - NON-FINAL ACTION - WRITTEN
Sunday, January 14, 2024NON-FINAL ACTION E-MAILED

Related Keywords

consulting clinical martian development drug medical regulatory strategy affairs pediatric oncology